Response to Yuce Sari et al.
Publication date
2021-05
Authors
Spampinato, Sofia
Fokdal, Lars U.
Pötter, Richard
Haie-Meder, Christine
Lindegaard, Jacob C.
Schmid, Maximilian P.
Sturdza, Alina
Jurgenliemk-Schulz, Ina M.
Mahantshetty, Umesh
Segedin, Barbara
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Cervical cancer, Clinical study, Dose-effect relationship, IGABT, Risk factors, Urinary morbidity, Uterine Cervical Neoplasms, Humans, Risk Factors, Fistula, Female, Brachytherapy, Cystitis, Taverne, Hematology, Oncology, Radiology Nuclear Medicine and imaging, Comment, Letter
Citation
Spampinato, S, Fokdal, L U, Pötter, R, Haie-Meder, C, Lindegaard, J C, Schmid, M P, Sturdza, A, Jürgenliemk-Schulz, I M, Mahantshetty, U, Segedin, B, Bruheim, K, Hoskin, P, Rai, B, Huang, F, Cooper, R, van der Steen-Banasik, E, Van Limbergen, E, Sundset, M, Westerveld, H, Nout, R A, Jensen, N B K, Kirisits, C, Kirchheiner, K & Tanderup, K 2021, 'Response to Yuce Sari et al.', Radiotherapy and Oncology, vol. 158, pp. 323-324. https://doi.org/10.1016/j.radonc.2021.02.022